| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 172 | 2024 | 1141 | 11.870 |
Why?
|
| Trinucleotide Repeat Expansion | 33 | 2022 | 247 | 3.160 |
Why?
|
| Nerve Tissue Proteins | 74 | 2019 | 4406 | 3.150 |
Why?
|
| Trinucleotide Repeats | 35 | 2017 | 257 | 2.290 |
Why?
|
| Nuclear Proteins | 63 | 2015 | 5786 | 2.180 |
Why?
|
| Chromosomes, Human, Pair 4 | 53 | 2015 | 377 | 1.960 |
Why?
|
| Corpus Striatum | 25 | 2018 | 1233 | 1.550 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 26 | 2010 | 783 | 1.020 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 10 | 2012 | 134 | 1.000 |
Why?
|
| Endodeoxyribonucleases | 3 | 2024 | 164 | 0.890 |
Why?
|
| Exodeoxyribonucleases | 3 | 2024 | 192 | 0.870 |
Why?
|
| Alleles | 43 | 2021 | 6895 | 0.830 |
Why?
|
| Age of Onset | 37 | 2021 | 3298 | 0.790 |
Why?
|
| Ribonucleotide Reductases | 1 | 2020 | 76 | 0.720 |
Why?
|
| Chromosome Mapping | 39 | 2008 | 4624 | 0.650 |
Why?
|
| Haplotypes | 21 | 2020 | 2764 | 0.580 |
Why?
|
| Peptides | 21 | 2012 | 4341 | 0.540 |
Why?
|
| Neurons | 37 | 2018 | 9416 | 0.540 |
Why?
|
| Polymorphism, Genetic | 20 | 2017 | 4284 | 0.520 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2013 | 892 | 0.490 |
Why?
|
| Crosses, Genetic | 6 | 2015 | 751 | 0.490 |
Why?
|
| Chromosomes, Mammalian | 2 | 2015 | 146 | 0.490 |
Why?
|
| Mutation | 47 | 2021 | 29915 | 0.490 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 1788 | 0.490 |
Why?
|
| Receptors, Dopamine | 2 | 2013 | 293 | 0.470 |
Why?
|
| Genetic Linkage | 21 | 2021 | 2381 | 0.440 |
Why?
|
| Disease Models, Animal | 28 | 2020 | 18119 | 0.440 |
Why?
|
| Thiolester Hydrolases | 3 | 2006 | 85 | 0.440 |
Why?
|
| Gene Expression Regulation | 18 | 2021 | 11892 | 0.390 |
Why?
|
| Mice, Transgenic | 25 | 2015 | 9518 | 0.370 |
Why?
|
| Heat-Shock Proteins | 2 | 2012 | 795 | 0.370 |
Why?
|
| Genetic Markers | 32 | 2006 | 2608 | 0.360 |
Why?
|
| Animals | 117 | 2021 | 167768 | 0.360 |
Why?
|
| Gene Expression | 11 | 2015 | 7583 | 0.350 |
Why?
|
| Heterozygote | 12 | 2024 | 2797 | 0.350 |
Why?
|
| Receptors, Kainic Acid | 3 | 2012 | 89 | 0.340 |
Why?
|
| Mice | 74 | 2020 | 81101 | 0.330 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 3442 | 0.320 |
Why?
|
| Molecular Chaperones | 5 | 2011 | 752 | 0.320 |
Why?
|
| Genes | 9 | 1999 | 1845 | 0.320 |
Why?
|
| DNA Repeat Expansion | 2 | 2006 | 72 | 0.310 |
Why?
|
| Phenotype | 24 | 2021 | 16534 | 0.310 |
Why?
|
| Metabolome | 1 | 2015 | 982 | 0.310 |
Why?
|
| Gene Knock-In Techniques | 9 | 2018 | 419 | 0.290 |
Why?
|
| Cerebellum | 6 | 2015 | 1497 | 0.290 |
Why?
|
| Polymorphism, Restriction Fragment Length | 21 | 2006 | 763 | 0.290 |
Why?
|
| Molecular Sequence Data | 37 | 2015 | 17617 | 0.290 |
Why?
|
| Quantitative Trait Loci | 2 | 2015 | 2100 | 0.280 |
Why?
|
| Neostriatum | 5 | 2018 | 246 | 0.280 |
Why?
|
| Mitochondria | 6 | 2007 | 3584 | 0.280 |
Why?
|
| Pedigree | 25 | 2021 | 4578 | 0.270 |
Why?
|
| Cell Line | 29 | 2021 | 15591 | 0.270 |
Why?
|
| Humans | 224 | 2024 | 758406 | 0.260 |
Why?
|
| Genetic Diseases, Inborn | 4 | 2002 | 601 | 0.260 |
Why?
|
| Gastrula | 1 | 2005 | 82 | 0.250 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 2717 | 0.250 |
Why?
|
| Translocation, Genetic | 8 | 2012 | 1387 | 0.250 |
Why?
|
| Minisatellite Repeats | 3 | 2007 | 164 | 0.250 |
Why?
|
| Genotype | 23 | 2019 | 12945 | 0.230 |
Why?
|
| Neurodegenerative Diseases | 5 | 2010 | 1081 | 0.230 |
Why?
|
| Base Sequence | 32 | 2015 | 12436 | 0.220 |
Why?
|
| Membrane Proteins | 9 | 2013 | 7843 | 0.220 |
Why?
|
| Genes, Dominant | 4 | 2006 | 862 | 0.210 |
Why?
|
| Recombination, Genetic | 8 | 1994 | 1526 | 0.210 |
Why?
|
| Drosophila | 3 | 2014 | 1491 | 0.210 |
Why?
|
| Brain | 25 | 2018 | 26947 | 0.210 |
Why?
|
| MicroRNAs | 4 | 2024 | 3783 | 0.210 |
Why?
|
| Membrane Glycoproteins | 5 | 2011 | 3705 | 0.200 |
Why?
|
| Dictyostelium | 2 | 2014 | 70 | 0.200 |
Why?
|
| Brain-Derived Neurotrophic Factor | 5 | 2007 | 597 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 12 | 2020 | 15773 | 0.200 |
Why?
|
| Cell Nucleus | 6 | 2006 | 2907 | 0.200 |
Why?
|
| Genome-Wide Association Study | 11 | 2024 | 12604 | 0.200 |
Why?
|
| Gene Expression Profiling | 7 | 2024 | 9404 | 0.200 |
Why?
|
| Exons | 11 | 2024 | 2387 | 0.190 |
Why?
|
| Repressor Proteins | 2 | 2009 | 2980 | 0.190 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2007 | 4485 | 0.190 |
Why?
|
| Molecular Biology | 3 | 2000 | 580 | 0.190 |
Why?
|
| Chromosome Breakage | 3 | 2012 | 159 | 0.190 |
Why?
|
| Chromosomes, Human | 4 | 2015 | 442 | 0.180 |
Why?
|
| Body Patterning | 1 | 2005 | 632 | 0.180 |
Why?
|
| Calcium Signaling | 1 | 2005 | 732 | 0.180 |
Why?
|
| DNA | 29 | 2022 | 7199 | 0.180 |
Why?
|
| Animals, Genetically Modified | 6 | 2013 | 1553 | 0.180 |
Why?
|
| Motor Skills Disorders | 1 | 2021 | 89 | 0.180 |
Why?
|
| Glutamine | 2 | 2002 | 575 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2012 | 3774 | 0.180 |
Why?
|
| Neural Stem Cells | 4 | 2017 | 882 | 0.180 |
Why?
|
| Energy Metabolism | 3 | 2007 | 2868 | 0.180 |
Why?
|
| Friend murine leukemia virus | 6 | 1981 | 37 | 0.180 |
Why?
|
| Karyopherins | 1 | 2000 | 130 | 0.170 |
Why?
|
| Restriction Mapping | 8 | 1996 | 852 | 0.170 |
Why?
|
| Models, Genetic | 7 | 2013 | 3441 | 0.170 |
Why?
|
| Genomic Instability | 3 | 2015 | 704 | 0.170 |
Why?
|
| Transcription Factors | 7 | 2012 | 12094 | 0.170 |
Why?
|
| Mice, Knockout | 9 | 2020 | 14354 | 0.170 |
Why?
|
| Cell Differentiation | 9 | 2019 | 11471 | 0.170 |
Why?
|
| Amino Acid Sequence | 15 | 2021 | 13447 | 0.170 |
Why?
|
| Venezuela | 6 | 2018 | 75 | 0.170 |
Why?
|
| Organelles | 2 | 2000 | 267 | 0.170 |
Why?
|
| 3' Untranslated Regions | 4 | 2024 | 514 | 0.160 |
Why?
|
| Gene Silencing | 1 | 2005 | 1507 | 0.160 |
Why?
|
| Cyclic AMP | 1 | 2003 | 1455 | 0.160 |
Why?
|
| Brain Chemistry | 5 | 2007 | 959 | 0.160 |
Why?
|
| Mice, Mutant Strains | 8 | 2009 | 1751 | 0.160 |
Why?
|
| Gene Targeting | 3 | 2005 | 837 | 0.160 |
Why?
|
| X Chromosome | 3 | 2021 | 815 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 17768 | 0.160 |
Why?
|
| Models, Biological | 7 | 2021 | 9460 | 0.150 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 2 | 2011 | 53 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 10 | 2021 | 4711 | 0.150 |
Why?
|
| DNA Repair | 2 | 2008 | 2038 | 0.150 |
Why?
|
| Cells, Cultured | 16 | 2011 | 18940 | 0.150 |
Why?
|
| Cerebral Cortex | 6 | 2015 | 5759 | 0.150 |
Why?
|
| Ubiquitins | 1 | 1999 | 366 | 0.150 |
Why?
|
| Male | 91 | 2021 | 358747 | 0.150 |
Why?
|
| Iduronidase | 3 | 1992 | 31 | 0.150 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 2 | 2015 | 29 | 0.150 |
Why?
|
| Cysteine Endopeptidases | 2 | 1999 | 548 | 0.150 |
Why?
|
| Organ Specificity | 4 | 2015 | 1955 | 0.140 |
Why?
|
| Craniofacial Abnormalities | 2 | 2012 | 315 | 0.140 |
Why?
|
| Family Health | 4 | 2018 | 1257 | 0.140 |
Why?
|
| Protozoan Proteins | 2 | 2014 | 839 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2009 | 2753 | 0.140 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2011 | 324 | 0.130 |
Why?
|
| Female | 82 | 2021 | 390323 | 0.130 |
Why?
|
| Genes, Homeobox | 2 | 2015 | 284 | 0.130 |
Why?
|
| Sequence Deletion | 6 | 2006 | 1492 | 0.130 |
Why?
|
| Homozygote | 6 | 2024 | 1788 | 0.130 |
Why?
|
| Gene Frequency | 10 | 2019 | 3612 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 855 | 0.130 |
Why?
|
| Multienzyme Complexes | 1 | 1999 | 665 | 0.130 |
Why?
|
| Genes, Developmental | 1 | 2015 | 38 | 0.130 |
Why?
|
| DNA, Complementary | 7 | 2006 | 1991 | 0.130 |
Why?
|
| Proteins | 5 | 2018 | 6026 | 0.130 |
Why?
|
| Germ-Line Mutation | 3 | 2012 | 1840 | 0.130 |
Why?
|
| Internationality | 1 | 2021 | 1000 | 0.130 |
Why?
|
| Iron | 2 | 2000 | 1786 | 0.130 |
Why?
|
| Immunoblotting | 6 | 2011 | 1647 | 0.120 |
Why?
|
| Chromosome Aberrations | 4 | 2008 | 1763 | 0.120 |
Why?
|
| RNA, Messenger | 13 | 2021 | 12759 | 0.120 |
Why?
|
| Linkage Disequilibrium | 5 | 2002 | 1996 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2012 | 410 | 0.120 |
Why?
|
| TATA-Box Binding Protein | 3 | 2003 | 99 | 0.120 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1994 | 116 | 0.120 |
Why?
|
| Penetrance | 3 | 2015 | 388 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 3 | 2009 | 1130 | 0.110 |
Why?
|
| Neuropsychological Tests | 3 | 2021 | 7021 | 0.110 |
Why?
|
| Chromosome Disorders | 3 | 2012 | 499 | 0.110 |
Why?
|
| Leukemia, Experimental | 5 | 1981 | 225 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 2 | 4 | 2012 | 313 | 0.110 |
Why?
|
| Autopsy | 5 | 2017 | 1003 | 0.110 |
Why?
|
| Edetic Acid | 1 | 2014 | 282 | 0.110 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 2 | 2006 | 48 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2014 | 23342 | 0.110 |
Why?
|
| Spermatozoa | 6 | 2007 | 631 | 0.110 |
Why?
|
| Sheep, Domestic | 1 | 2013 | 50 | 0.110 |
Why?
|
| Mutagenesis, Insertional | 3 | 2002 | 652 | 0.110 |
Why?
|
| Transcription, Genetic | 7 | 2003 | 7590 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2013 | 485 | 0.100 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2013 | 170 | 0.100 |
Why?
|
| Adipose Tissue, White | 1 | 2015 | 365 | 0.100 |
Why?
|
| Central Nervous System Diseases | 1 | 2017 | 520 | 0.100 |
Why?
|
| Cosmids | 7 | 1994 | 105 | 0.100 |
Why?
|
| Databases, Genetic | 2 | 2014 | 1737 | 0.100 |
Why?
|
| Cluster Analysis | 5 | 2015 | 2697 | 0.100 |
Why?
|
| Codon, Terminator | 1 | 2012 | 125 | 0.100 |
Why?
|
| Genetics, Population | 2 | 2018 | 929 | 0.100 |
Why?
|
| Heterochromatin | 1 | 2014 | 293 | 0.100 |
Why?
|
| Chorea | 2 | 2002 | 79 | 0.100 |
Why?
|
| Embryonic Stem Cells | 3 | 2017 | 1262 | 0.100 |
Why?
|
| Solubility | 4 | 2003 | 1088 | 0.100 |
Why?
|
| Gene Deletion | 4 | 2015 | 2666 | 0.090 |
Why?
|
| Precipitin Tests | 3 | 2003 | 814 | 0.090 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2013 | 251 | 0.090 |
Why?
|
| Meclizine | 1 | 2010 | 13 | 0.090 |
Why?
|
| Cell Transformation, Viral | 6 | 1987 | 526 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 933 | 0.090 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2013 | 415 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2014 | 1074 | 0.090 |
Why?
|
| Cloning, Molecular | 11 | 1998 | 4169 | 0.090 |
Why?
|
| Acetylesterase | 1 | 2010 | 14 | 0.090 |
Why?
|
| Disease Management | 1 | 2021 | 2500 | 0.090 |
Why?
|
| Cell Death | 5 | 2005 | 1668 | 0.090 |
Why?
|
| Aneuploidy | 1 | 1994 | 551 | 0.090 |
Why?
|
| Parkinson Disease | 4 | 2008 | 2862 | 0.090 |
Why?
|
| Gene Library | 8 | 2001 | 1059 | 0.090 |
Why?
|
| Adult | 46 | 2021 | 219935 | 0.090 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2010 | 99 | 0.090 |
Why?
|
| Genetic Variation | 7 | 2015 | 6548 | 0.090 |
Why?
|
| Europe | 3 | 2012 | 3420 | 0.090 |
Why?
|
| Genetic Testing | 7 | 2007 | 3530 | 0.090 |
Why?
|
| Genetic Pleiotropy | 1 | 2011 | 181 | 0.090 |
Why?
|
| Cell Adhesion | 2 | 2014 | 3090 | 0.090 |
Why?
|
| Serine | 2 | 2004 | 828 | 0.080 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2010 | 173 | 0.080 |
Why?
|
| Nerve Degeneration | 5 | 2006 | 748 | 0.080 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 755 | 0.080 |
Why?
|
| Middle Aged | 46 | 2021 | 219568 | 0.080 |
Why?
|
| Potassium Channels | 1 | 2012 | 534 | 0.080 |
Why?
|
| Gliosis | 2 | 2012 | 244 | 0.080 |
Why?
|
| Caspase 3 | 3 | 2006 | 728 | 0.080 |
Why?
|
| Receptors, Transferrin | 2 | 2000 | 291 | 0.080 |
Why?
|
| Caudate Nucleus | 3 | 2012 | 389 | 0.080 |
Why?
|
| Golgi Apparatus | 2 | 2000 | 404 | 0.080 |
Why?
|
| Neuroglia | 2 | 2012 | 944 | 0.080 |
Why?
|
| Neurites | 1 | 2011 | 390 | 0.080 |
Why?
|
| Sequence Alignment | 3 | 2021 | 2176 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2000 | 4938 | 0.080 |
Why?
|
| Crossing Over, Genetic | 3 | 1994 | 95 | 0.080 |
Why?
|
| Cytoplasm | 3 | 2009 | 1514 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2017 | 362 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2017 | 1842 | 0.080 |
Why?
|
| DNA Mutational Analysis | 6 | 2006 | 4106 | 0.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2015 | 1463 | 0.080 |
Why?
|
| DNA-Binding Proteins | 4 | 2008 | 9574 | 0.080 |
Why?
|
| Synapses | 1 | 2018 | 1757 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1120 | 0.080 |
Why?
|
| Adenosine Triphosphate | 4 | 2011 | 1986 | 0.080 |
Why?
|
| Founder Effect | 3 | 2015 | 186 | 0.080 |
Why?
|
| Behavior, Animal | 4 | 2013 | 1866 | 0.080 |
Why?
|
| Astrocytes | 3 | 2011 | 1337 | 0.070 |
Why?
|
| DNA Probes | 8 | 1993 | 543 | 0.070 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 2001 | 0.070 |
Why?
|
| Mutant Proteins | 2 | 2011 | 491 | 0.070 |
Why?
|
| Apoptosis | 8 | 2010 | 9468 | 0.070 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 718 | 0.070 |
Why?
|
| Hybrid Cells | 8 | 1997 | 422 | 0.070 |
Why?
|
| HEK293 Cells | 4 | 2020 | 4257 | 0.070 |
Why?
|
| Stem Cells | 5 | 2006 | 3521 | 0.070 |
Why?
|
| Genes, Viral | 3 | 1987 | 649 | 0.070 |
Why?
|
| Gingival Hyperplasia | 1 | 2007 | 19 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2014 | 2057 | 0.070 |
Why?
|
| Receptors, HIV | 2 | 1999 | 159 | 0.070 |
Why?
|
| Sheep | 1 | 2010 | 1441 | 0.070 |
Why?
|
| Inheritance Patterns | 1 | 2009 | 340 | 0.070 |
Why?
|
| Receptor, trkB | 1 | 2007 | 125 | 0.070 |
Why?
|
| Hypertrichosis | 1 | 2007 | 31 | 0.070 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2008 | 195 | 0.070 |
Why?
|
| Neuropeptides | 2 | 2014 | 943 | 0.070 |
Why?
|
| Human Development | 1 | 2008 | 123 | 0.070 |
Why?
|
| Receptors, Cytokine | 2 | 1999 | 258 | 0.070 |
Why?
|
| Genome, Human | 8 | 2008 | 4416 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1895 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 1885 | 0.070 |
Why?
|
| Cytochromes c | 2 | 2004 | 173 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2021 | 3975 | 0.070 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 1122 | 0.070 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2006 | 16 | 0.070 |
Why?
|
| Neurologic Examination | 2 | 2007 | 914 | 0.070 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2006 | 100 | 0.070 |
Why?
|
| Cricetinae | 8 | 1997 | 2426 | 0.070 |
Why?
|
| Phosphorylation | 4 | 2006 | 8297 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 10 | 2010 | 6068 | 0.070 |
Why?
|
| Enzyme Activation | 4 | 2006 | 3593 | 0.070 |
Why?
|
| Quinolinic Acid | 1 | 2006 | 67 | 0.070 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2006 | 122 | 0.070 |
Why?
|
| Cadherins | 1 | 2011 | 898 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 1994 | 778 | 0.070 |
Why?
|
| Herbicides | 1 | 2006 | 104 | 0.070 |
Why?
|
| Multigene Family | 1 | 1989 | 1076 | 0.070 |
Why?
|
| Leukemia, Erythroblastic, Acute | 3 | 1981 | 176 | 0.070 |
Why?
|
| Inclusion Bodies | 3 | 2005 | 281 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2014 | 3602 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2007 | 315 | 0.060 |
Why?
|
| Neuroprotective Agents | 3 | 2014 | 955 | 0.060 |
Why?
|
| Polycythemia | 3 | 1981 | 125 | 0.060 |
Why?
|
| Kynurenine | 1 | 2006 | 139 | 0.060 |
Why?
|
| Growth and Development | 1 | 2005 | 47 | 0.060 |
Why?
|
| Sp1 Transcription Factor | 1 | 2006 | 140 | 0.060 |
Why?
|
| Rats | 11 | 2014 | 23679 | 0.060 |
Why?
|
| Immunoglobulin Fragments | 1 | 2005 | 84 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2006 | 373 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 1987 | 412 | 0.060 |
Why?
|
| Internet | 3 | 2015 | 3082 | 0.060 |
Why?
|
| Chromosome Deletion | 3 | 2012 | 1387 | 0.060 |
Why?
|
| Transgenes | 2 | 2010 | 1007 | 0.060 |
Why?
|
| Down-Regulation | 3 | 2007 | 2904 | 0.060 |
Why?
|
| Developmental Disabilities | 2 | 2012 | 1504 | 0.060 |
Why?
|
| Alternative Splicing | 3 | 2012 | 1090 | 0.060 |
Why?
|
| Basal Ganglia Diseases | 1 | 2005 | 144 | 0.060 |
Why?
|
| Chromatin | 2 | 2015 | 2938 | 0.060 |
Why?
|
| Motor Activity | 3 | 2013 | 2685 | 0.060 |
Why?
|
| Rotarod Performance Test | 2 | 2014 | 63 | 0.060 |
Why?
|
| Transfection | 7 | 2003 | 5779 | 0.060 |
Why?
|
| Kallmann Syndrome | 1 | 2005 | 139 | 0.060 |
Why?
|
| Adenosine Diphosphate | 1 | 2005 | 422 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2006 | 490 | 0.060 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2004 | 73 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1740 | 0.060 |
Why?
|
| Protein Binding | 4 | 2009 | 9311 | 0.060 |
Why?
|
| Biotin | 1 | 2005 | 253 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2005 | 256 | 0.060 |
Why?
|
| Neural Pathways | 2 | 2013 | 3039 | 0.060 |
Why?
|
| Electron Transport Complex II | 1 | 2004 | 53 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2011 | 1743 | 0.060 |
Why?
|
| Aged | 33 | 2021 | 168218 | 0.060 |
Why?
|
| Body Weight | 1 | 2015 | 4603 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2006 | 427 | 0.060 |
Why?
|
| Immunohistochemistry | 8 | 2011 | 11070 | 0.060 |
Why?
|
| Intracellular Membranes | 2 | 2004 | 389 | 0.060 |
Why?
|
| Histones | 2 | 2015 | 2577 | 0.060 |
Why?
|
| Chromones | 1 | 2003 | 148 | 0.060 |
Why?
|
| Chromosomes, Fungal | 6 | 1993 | 111 | 0.060 |
Why?
|
| Microsatellite Instability | 1 | 2007 | 715 | 0.060 |
Why?
|
| Mitochondria, Liver | 1 | 2004 | 190 | 0.060 |
Why?
|
| Caspases | 3 | 2004 | 876 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 2 | 1986 | 1156 | 0.050 |
Why?
|
| Glycoproteins | 4 | 2008 | 2205 | 0.050 |
Why?
|
| Microscopy, Electron | 2 | 2006 | 2557 | 0.050 |
Why?
|
| Axonal Transport | 1 | 2003 | 178 | 0.050 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 704 | 0.050 |
Why?
|
| Fibroblasts | 6 | 2017 | 4087 | 0.050 |
Why?
|
| Introns | 4 | 2006 | 978 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2007 | 786 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2006 | 1134 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2010 | 1358 | 0.050 |
Why?
|
| Codon | 2 | 1994 | 602 | 0.050 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2003 | 104 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 9 | 2018 | 22003 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2005 | 1674 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2001 | 84 | 0.050 |
Why?
|
| Cell Size | 3 | 2014 | 623 | 0.050 |
Why?
|
| Tachykinins | 1 | 2002 | 77 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2002 | 286 | 0.050 |
Why?
|
| Costa Rica | 1 | 2001 | 177 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2003 | 240 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 2 | 2007 | 1342 | 0.050 |
Why?
|
| Genes, Reporter | 3 | 2019 | 1527 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 940 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2003 | 408 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2009 | 1398 | 0.050 |
Why?
|
| Cyclin D1 | 1 | 2003 | 451 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 6 | 2006 | 5779 | 0.050 |
Why?
|
| Somatosensory Cortex | 1 | 2005 | 511 | 0.050 |
Why?
|
| Defective Viruses | 1 | 1981 | 89 | 0.050 |
Why?
|
| Cholesterol | 1 | 2010 | 2902 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2002 | 226 | 0.050 |
Why?
|
| Glutathione Transferase | 2 | 2000 | 564 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2014 | 5031 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2021 | 6803 | 0.050 |
Why?
|
| Drosophila melanogaster | 2 | 2010 | 1710 | 0.050 |
Why?
|
| Clone Cells | 3 | 2000 | 1660 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2017 | 452 | 0.050 |
Why?
|
| Adolescent | 18 | 2016 | 87892 | 0.050 |
Why?
|
| Tretinoin | 2 | 2001 | 519 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 483 | 0.050 |
Why?
|
| Branchial Region | 1 | 2000 | 35 | 0.040 |
Why?
|
| Education, Professional | 1 | 2000 | 51 | 0.040 |
Why?
|
| Child, Preschool | 11 | 2021 | 42062 | 0.040 |
Why?
|
| Aged, 80 and over | 15 | 2016 | 58683 | 0.040 |
Why?
|
| Drosophila Proteins | 2 | 2014 | 1699 | 0.040 |
Why?
|
| Morpholines | 1 | 2003 | 580 | 0.040 |
Why?
|
| Cytosol | 1 | 2003 | 886 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1693 | 0.040 |
Why?
|
| Tissue Distribution | 3 | 2010 | 2262 | 0.040 |
Why?
|
| Intranuclear Inclusion Bodies | 2 | 2013 | 34 | 0.040 |
Why?
|
| Sodium Channels | 2 | 2012 | 343 | 0.040 |
Why?
|
| Cell Survival | 6 | 2011 | 5781 | 0.040 |
Why?
|
| Research | 2 | 2002 | 1976 | 0.040 |
Why?
|
| Transglutaminases | 1 | 2001 | 197 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 1312 | 0.040 |
Why?
|
| Cleft Lip | 1 | 2005 | 504 | 0.040 |
Why?
|
| Spliceosomes | 1 | 2000 | 129 | 0.040 |
Why?
|
| Immune Sera | 1 | 2000 | 613 | 0.040 |
Why?
|
| Liver | 1 | 2015 | 7502 | 0.040 |
Why?
|
| Cohort Studies | 8 | 2016 | 41256 | 0.040 |
Why?
|
| Transferrin | 1 | 2000 | 284 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2003 | 3733 | 0.040 |
Why?
|
| Cleft Palate | 1 | 2005 | 587 | 0.040 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1999 | 93 | 0.040 |
Why?
|
| Visual Pathways | 1 | 2003 | 534 | 0.040 |
Why?
|
| Receptors, CCR5 | 2 | 1999 | 487 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 2006 | 144 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 1034 | 0.040 |
Why?
|
| Ion Channels | 1 | 2004 | 1043 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2000 | 435 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2003 | 1218 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2001 | 468 | 0.040 |
Why?
|
| Disease Progression | 6 | 2015 | 13468 | 0.040 |
Why?
|
| RNA Splicing | 2 | 2021 | 913 | 0.040 |
Why?
|
| Genetics, Medical | 1 | 2002 | 336 | 0.040 |
Why?
|
| Spinocerebellar Degenerations | 2 | 1996 | 44 | 0.040 |
Why?
|
| Thalamus | 1 | 2005 | 1040 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2007 | 2504 | 0.040 |
Why?
|
| Neocortex | 1 | 2003 | 416 | 0.040 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 1998 | 39 | 0.040 |
Why?
|
| Recombinant Proteins | 5 | 2004 | 6520 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 5 | 1993 | 1304 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 1996 | 2105 | 0.040 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 1998 | 10 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 2895 | 0.040 |
Why?
|
| Mitosis | 2 | 2006 | 1191 | 0.040 |
Why?
|
| Breast Diseases | 1 | 2001 | 443 | 0.040 |
Why?
|
| Microtubules | 1 | 2004 | 1072 | 0.040 |
Why?
|
| Occupational Diseases | 1 | 2006 | 1486 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3796 | 0.040 |
Why?
|
| RNA | 2 | 2000 | 2716 | 0.040 |
Why?
|
| Child | 12 | 2021 | 79818 | 0.040 |
Why?
|
| beta Catenin | 1 | 2003 | 1043 | 0.040 |
Why?
|
| Myotonic Dystrophy | 2 | 1996 | 78 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2003 | 2640 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2008 | 1216 | 0.040 |
Why?
|
| Autophagy | 1 | 2006 | 1322 | 0.040 |
Why?
|
| Bone Diseases | 1 | 2001 | 419 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2359 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 2244 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2015 | 3615 | 0.040 |
Why?
|
| Endosomes | 1 | 2000 | 519 | 0.040 |
Why?
|
| Erythrocyte Membrane | 2 | 1979 | 439 | 0.040 |
Why?
|
| Lymphocytes | 2 | 2012 | 2610 | 0.040 |
Why?
|
| Erythropoiesis | 2 | 1979 | 682 | 0.040 |
Why?
|
| Sex Characteristics | 3 | 2009 | 2621 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2002 | 1133 | 0.040 |
Why?
|
| Interneurons | 2 | 2005 | 591 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2000 | 540 | 0.040 |
Why?
|
| Peptide Initiation Factors | 1 | 1997 | 55 | 0.040 |
Why?
|
| Iron-Binding Proteins | 1 | 1997 | 79 | 0.040 |
Why?
|
| Time Factors | 7 | 2021 | 39872 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2003 | 1077 | 0.040 |
Why?
|
| Models, Animal | 1 | 2003 | 2112 | 0.040 |
Why?
|
| In Situ Hybridization | 3 | 1996 | 1900 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2000 | 1969 | 0.040 |
Why?
|
| Age Factors | 6 | 2016 | 18358 | 0.030 |
Why?
|
| Genome | 2 | 2003 | 1739 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1997 | 420 | 0.030 |
Why?
|
| Australia | 3 | 2006 | 1276 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 3 | 1991 | 168 | 0.030 |
Why?
|
| Friedreich Ataxia | 1 | 1997 | 77 | 0.030 |
Why?
|
| Meiosis | 1 | 1999 | 328 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 1887 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2021 | 2564 | 0.030 |
Why?
|
| Depressive Disorder, Major | 2 | 2015 | 4745 | 0.030 |
Why?
|
| Species Specificity | 3 | 1998 | 2417 | 0.030 |
Why?
|
| Gait | 1 | 2002 | 812 | 0.030 |
Why?
|
| Cartilage | 1 | 2000 | 806 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1999 | 498 | 0.030 |
Why?
|
| Occupational Exposure | 1 | 2006 | 1809 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 1999 | 454 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1998 | 412 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2003 | 2860 | 0.030 |
Why?
|
| Inflammation | 1 | 2015 | 10718 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 1999 | 655 | 0.030 |
Why?
|
| Hypergammaglobulinemia | 1 | 1975 | 72 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 3709 | 0.030 |
Why?
|
| Italy | 2 | 1994 | 839 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2002 | 1333 | 0.030 |
Why?
|
| Reference Values | 3 | 2001 | 4919 | 0.030 |
Why?
|
| Portugal | 1 | 2015 | 91 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 435 | 0.030 |
Why?
|
| Nondisjunction, Genetic | 1 | 1994 | 24 | 0.030 |
Why?
|
| Computational Biology | 2 | 2010 | 3502 | 0.030 |
Why?
|
| Gaucher Disease | 1 | 1975 | 110 | 0.030 |
Why?
|
| Metaphase | 2 | 1992 | 144 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 2443 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 20055 | 0.030 |
Why?
|
| Base Pairing | 1 | 2015 | 140 | 0.030 |
Why?
|
| Cell Line, Transformed | 2 | 2007 | 869 | 0.030 |
Why?
|
| Binding Sites | 2 | 2006 | 6036 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2004 | 8143 | 0.030 |
Why?
|
| Protein Conformation | 2 | 1999 | 3966 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4567 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 2413 | 0.030 |
Why?
|
| Histological Techniques | 1 | 1995 | 194 | 0.030 |
Why?
|
| Fragile X Syndrome | 1 | 1996 | 116 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 1997 | 409 | 0.030 |
Why?
|
| Lod Score | 3 | 2002 | 602 | 0.030 |
Why?
|
| Hemoglobins | 3 | 1981 | 1519 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2858 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2013 | 107 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2003 | 3680 | 0.030 |
Why?
|
| Receptors, Purinergic P1 | 1 | 1994 | 108 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2014 | 317 | 0.030 |
Why?
|
| Greece | 2 | 2006 | 336 | 0.030 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 8544 | 0.030 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2014 | 200 | 0.030 |
Why?
|
| Adenine | 2 | 2011 | 975 | 0.030 |
Why?
|
| Mefloquine | 1 | 1993 | 55 | 0.030 |
Why?
|
| Amyloid | 1 | 1998 | 841 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1994 | 346 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2012 | 93 | 0.030 |
Why?
|
| Lactic Acid | 1 | 1998 | 1133 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 3 | 2006 | 2057 | 0.030 |
Why?
|
| Genetic Vectors | 3 | 2014 | 3380 | 0.030 |
Why?
|
| Antigens | 1 | 1978 | 1445 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2002 | 1585 | 0.030 |
Why?
|
| Gene Order | 1 | 2012 | 169 | 0.030 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2012 | 29 | 0.030 |
Why?
|
| Peptide Fragments | 3 | 1999 | 5098 | 0.030 |
Why?
|
| Growth Disorders | 1 | 1997 | 653 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 1997 | 621 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 1999 | 1264 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1994 | 1543 | 0.030 |
Why?
|
| Chromosome Banding | 2 | 1993 | 260 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 857 | 0.020 |
Why?
|
| North America | 2 | 2006 | 1276 | 0.020 |
Why?
|
| Cadaver | 2 | 2012 | 1345 | 0.020 |
Why?
|
| Syndrome | 3 | 2007 | 3262 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 3432 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 1993 | 469 | 0.020 |
Why?
|
| Facial Bones | 1 | 1993 | 205 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 3609 | 0.020 |
Why?
|
| Spores, Protozoan | 1 | 2011 | 5 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 1993 | 447 | 0.020 |
Why?
|
| Methylation | 1 | 2014 | 1080 | 0.020 |
Why?
|
| Pregnancy | 4 | 2004 | 29742 | 0.020 |
Why?
|
| Smell | 1 | 2013 | 259 | 0.020 |
Why?
|
| Chromosome Inversion | 1 | 2012 | 120 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 1992 | 286 | 0.020 |
Why?
|
| Cyclosporine | 2 | 2004 | 777 | 0.020 |
Why?
|
| Face | 1 | 1997 | 1017 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2011 | 168 | 0.020 |
Why?
|
| Calcium | 1 | 2004 | 5721 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2001 | 1647 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2011 | 137 | 0.020 |
Why?
|
| Microglia | 2 | 2013 | 1349 | 0.020 |
Why?
|
| Structure-Activity Relationship | 3 | 2003 | 3069 | 0.020 |
Why?
|
| DNA Primers | 2 | 2011 | 2816 | 0.020 |
Why?
|
| Aging | 3 | 2009 | 8650 | 0.020 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2010 | 51 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2010 | 2672 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1136 | 0.020 |
Why?
|
| Case-Control Studies | 4 | 2012 | 22029 | 0.020 |
Why?
|
| Sterols | 1 | 2010 | 62 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2010 | 115 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 4 | 2003 | 6127 | 0.020 |
Why?
|
| Mosaicism | 1 | 1993 | 465 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 327 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 633 | 0.020 |
Why?
|
| History, 19th Century | 1 | 1993 | 720 | 0.020 |
Why?
|
| Probability | 2 | 2007 | 2467 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2006 | 3096 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2000 | 2912 | 0.020 |
Why?
|
| Cell Respiration | 1 | 2010 | 202 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1991 | 430 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1995 | 707 | 0.020 |
Why?
|
| Biological Transport | 2 | 2004 | 2084 | 0.020 |
Why?
|
| Ovary | 1 | 2014 | 958 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1990 | 217 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2001 | 276 | 0.020 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1994 | 529 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 170 | 0.020 |
Why?
|
| Prevalence | 4 | 2015 | 15651 | 0.020 |
Why?
|
| Simian virus 40 | 2 | 1987 | 291 | 0.020 |
Why?
|
| Lysosomes | 2 | 2005 | 919 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 802 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 2 | 1998 | 2695 | 0.020 |
Why?
|
| BK Virus | 2 | 1987 | 123 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1978 | 2413 | 0.020 |
Why?
|
| Mice, Inbred Strains | 3 | 2006 | 1759 | 0.020 |
Why?
|
| Oxygen | 1 | 2000 | 4191 | 0.020 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 137 | 0.020 |
Why?
|
| Family | 2 | 2015 | 3188 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1997 | 1275 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2002 | 3047 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2850 | 0.020 |
Why?
|
| Cell Nucleolus | 1 | 2009 | 156 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2010 | 344 | 0.020 |
Why?
|
| Linear Models | 2 | 2015 | 5862 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 3 | 1996 | 3384 | 0.020 |
Why?
|
| Young Adult | 5 | 2016 | 58808 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 2013 | 697 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1996 | 1613 | 0.020 |
Why?
|
| Retroviridae | 2 | 2001 | 850 | 0.020 |
Why?
|
| Cystic Fibrosis | 2 | 1997 | 1274 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 1994 | 911 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 1429 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 2470 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 458 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2007 | 48 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2011 | 598 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 746 | 0.020 |
Why?
|
| Genes, Regulator | 2 | 1987 | 374 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2872 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 3759 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2007 | 119 | 0.020 |
Why?
|
| COS Cells | 2 | 2001 | 1128 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 835 | 0.020 |
Why?
|
| Antigens, Surface | 3 | 1980 | 1607 | 0.020 |
Why?
|
| Prefrontal Cortex | 2 | 2014 | 2209 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2008 | 199 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1060 | 0.020 |
Why?
|
| Public Health | 1 | 2000 | 2658 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 2252 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2011 | 942 | 0.020 |
Why?
|
| Parents | 2 | 2007 | 3548 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2012 | 837 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2011 | 740 | 0.020 |
Why?
|
| RNA-Binding Proteins | 2 | 2009 | 1894 | 0.020 |
Why?
|
| Birth Order | 1 | 2007 | 95 | 0.020 |
Why?
|
| Social Behavior | 1 | 2013 | 1131 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 2010 | 552 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 838 | 0.020 |
Why?
|
| Muscles | 1 | 1992 | 1579 | 0.020 |
Why?
|
| Putamen | 1 | 2007 | 291 | 0.020 |
Why?
|
| Chromosomes, Human, 4-5 | 1 | 1986 | 26 | 0.020 |
Why?
|
| Caenorhabditis elegans | 2 | 2010 | 1444 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2017 | 10416 | 0.020 |
Why?
|
| Kynurenic Acid | 1 | 2006 | 44 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2006 | 151 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2010 | 652 | 0.020 |
Why?
|
| Fibrin | 2 | 1986 | 505 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2006 | 340 | 0.020 |
Why?
|
| Telomere | 1 | 1992 | 931 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2006 | 416 | 0.020 |
Why?
|
| Spleen | 3 | 1981 | 2296 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2010 | 663 | 0.020 |
Why?
|
| Turkey | 1 | 2006 | 249 | 0.020 |
Why?
|
| Polyomavirus | 1 | 1987 | 234 | 0.020 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2005 | 20 | 0.020 |
Why?
|
| Ceroid | 1 | 2005 | 6 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2006 | 182 | 0.020 |
Why?
|
| Karyotyping | 3 | 1997 | 1171 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6234 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 2379 | 0.020 |
Why?
|
| Glucose | 2 | 2013 | 4336 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1993 | 1414 | 0.020 |
Why?
|
| Cricetulus | 1 | 1987 | 815 | 0.020 |
Why?
|
| Blotting, Southern | 3 | 1991 | 777 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2007 | 462 | 0.020 |
Why?
|
| Cytosine | 1 | 2006 | 210 | 0.020 |
Why?
|
| Gossypol | 1 | 2005 | 23 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 240 | 0.020 |
Why?
|
| Guanine | 1 | 2006 | 278 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2006 | 23884 | 0.020 |
Why?
|
| Olfaction Disorders | 1 | 2007 | 224 | 0.020 |
Why?
|
| DNA, Recombinant | 4 | 1987 | 455 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2005 | 337 | 0.020 |
Why?
|
| Cathepsin D | 1 | 2004 | 59 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2013 | 2322 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 877 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 2646 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2006 | 183 | 0.020 |
Why?
|
| Valine | 1 | 2006 | 408 | 0.020 |
Why?
|
| Gestational Age | 1 | 1993 | 3565 | 0.010 |
Why?
|
| History, 20th Century | 1 | 1993 | 2772 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 1436 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2005 | 310 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2005 | 239 | 0.010 |
Why?
|
| Seizures | 1 | 1997 | 2919 | 0.010 |
Why?
|
| Viral Proteins | 2 | 2003 | 1801 | 0.010 |
Why?
|
| Ruthenium Red | 1 | 2004 | 19 | 0.010 |
Why?
|
| Fathers | 1 | 2007 | 377 | 0.010 |
Why?
|
| Cognition | 1 | 2022 | 6953 | 0.010 |
Why?
|
| MSX1 Transcription Factor | 1 | 2004 | 53 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 2004 | 46 | 0.010 |
Why?
|
| Rotenone | 1 | 2004 | 45 | 0.010 |
Why?
|
| Malaria, Falciparum | 1 | 1993 | 1076 | 0.010 |
Why?
|
| Hepatitis C | 1 | 1994 | 1579 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 293 | 0.010 |
Why?
|
| Nitro Compounds | 1 | 2004 | 74 | 0.010 |
Why?
|
| Learning | 1 | 2013 | 1739 | 0.010 |
Why?
|
| Methionine | 1 | 2006 | 569 | 0.010 |
Why?
|
| Toxins, Biological | 1 | 2004 | 60 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2006 | 550 | 0.010 |
Why?
|
| Neuroblastoma | 2 | 2003 | 1251 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6493 | 0.010 |
Why?
|
| Decapodiformes | 1 | 2003 | 36 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2004 | 185 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2049 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 16886 | 0.010 |
Why?
|
| Infant | 5 | 2012 | 36055 | 0.010 |
Why?
|
| Propionates | 1 | 2004 | 182 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1986 | 1433 | 0.010 |
Why?
|
| Siblings | 1 | 2007 | 824 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 532 | 0.010 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2004 | 158 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 1993 | 1742 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2004 | 410 | 0.010 |
Why?
|
| Kainic Acid | 1 | 2003 | 198 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2007 | 719 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1177 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 12096 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 9160 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2005 | 626 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 1539 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 2003 | 231 | 0.010 |
Why?
|
| DNA, Viral | 2 | 1996 | 2194 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 10748 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1986 | 772 | 0.010 |
Why?
|
| Calpain | 1 | 2002 | 145 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1734 | 0.010 |
Why?
|
| Enkephalins | 1 | 2002 | 139 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2002 | 384 | 0.010 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2001 | 74 | 0.010 |
Why?
|
| Culture Media | 2 | 1981 | 899 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 3 | 1988 | 553 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1986 | 1792 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 2001 | 190 | 0.010 |
Why?
|
| Helper Viruses | 1 | 1981 | 40 | 0.010 |
Why?
|
| Mental Recall | 1 | 2007 | 1208 | 0.010 |
Why?
|
| Genes, p16 | 1 | 2001 | 159 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2004 | 560 | 0.010 |
Why?
|
| Reaction Time | 1 | 2007 | 2075 | 0.010 |
Why?
|
| Dystonia Musculorum Deformans | 1 | 2001 | 158 | 0.010 |
Why?
|
| Leukemia Virus, Murine | 1 | 1981 | 94 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 449 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2002 | 313 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1981 | 351 | 0.010 |
Why?
|
| Substance P | 1 | 2002 | 333 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 2 | 1979 | 251 | 0.010 |
Why?
|
| Zebrafish | 1 | 2012 | 2993 | 0.010 |
Why?
|
| Integrases | 1 | 2003 | 516 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 2002 | 250 | 0.010 |
Why?
|
| Polyamines | 1 | 2001 | 133 | 0.010 |
Why?
|
| Anemia | 2 | 1980 | 1504 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 1094 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 1986 | 1020 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3801 | 0.010 |
Why?
|
| Virus Replication | 2 | 1996 | 2430 | 0.010 |
Why?
|
| Endocytosis | 1 | 2004 | 958 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2010 | 6354 | 0.010 |
Why?
|
| Japan | 1 | 2004 | 1366 | 0.010 |
Why?
|
| Professional Competence | 2 | 2000 | 431 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 36284 | 0.010 |
Why?
|
| Rhombencephalon | 1 | 2000 | 81 | 0.010 |
Why?
|
| New England | 1 | 2003 | 1053 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1981 | 622 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1987 | 1356 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 1133 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2001 | 342 | 0.010 |
Why?
|
| Age Distribution | 1 | 2006 | 2882 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 1055 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 1752 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2001 | 534 | 0.010 |
Why?
|
| International Cooperation | 1 | 2006 | 1430 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2001 | 1084 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 1335 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 2003 | 589 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2001 | 712 | 0.010 |
Why?
|
| Education, Nursing, Diploma Programs | 1 | 1978 | 11 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2001 | 635 | 0.010 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2002 | 485 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2006 | 1610 | 0.010 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 1978 | 20 | 0.010 |
Why?
|
| HIV-1 | 1 | 1996 | 6850 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 12951 | 0.010 |
Why?
|
| Anxiety | 1 | 2013 | 4539 | 0.010 |
Why?
|
| Hemin | 1 | 1978 | 50 | 0.010 |
Why?
|
| Industry | 1 | 2000 | 361 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 698 | 0.010 |
Why?
|
| TATA Box | 1 | 1998 | 127 | 0.010 |
Why?
|
| Dopamine | 1 | 2006 | 1599 | 0.010 |
Why?
|
| Ouabain | 1 | 1978 | 247 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 2001 | 562 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2000 | 981 | 0.010 |
Why?
|
| Survival Rate | 2 | 2003 | 12721 | 0.010 |
Why?
|
| Sex Factors | 2 | 2007 | 10504 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 1999 | 172 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1694 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 1999 | 215 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2010 | 9650 | 0.010 |
Why?
|
| Neural Crest | 1 | 2000 | 279 | 0.010 |
Why?
|
| Environment | 1 | 2004 | 1118 | 0.010 |
Why?
|
| Movement Disorders | 1 | 2001 | 459 | 0.010 |
Why?
|
| Netherlands | 1 | 2002 | 2212 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2015 | 5079 | 0.010 |
Why?
|
| Attention | 1 | 2007 | 2387 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 2836 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 1233 | 0.010 |
Why?
|
| Blood Donors | 1 | 1999 | 343 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 4738 | 0.010 |
Why?
|
| Acetamides | 1 | 1978 | 255 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 1997 | 145 | 0.010 |
Why?
|
| G-Protein-Coupled Receptor Kinase 4 | 1 | 1996 | 3 | 0.010 |
Why?
|
| Mothers | 1 | 2007 | 2189 | 0.010 |
Why?
|
| Touch | 1 | 1999 | 312 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 1997 | 112 | 0.010 |
Why?
|
| Antigens, Viral, Tumor | 2 | 1987 | 153 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1981 | 719 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1996 | 52 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 1980 | 980 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2006 | 5410 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2004 | 1927 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1980 | 1244 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 3432 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1997 | 436 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 1664 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1998 | 1165 | 0.010 |
Why?
|
| Lung | 1 | 2013 | 9985 | 0.010 |
Why?
|
| Potassium | 1 | 1979 | 1310 | 0.010 |
Why?
|
| New South Wales | 1 | 1994 | 70 | 0.010 |
Why?
|
| Risk Factors | 3 | 2012 | 73809 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3755 | 0.010 |
Why?
|
| Chemokines | 1 | 1999 | 961 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2009 | 5070 | 0.010 |
Why?
|
| Chromosome Fragility | 1 | 1994 | 16 | 0.010 |
Why?
|
| Program Development | 1 | 2000 | 1298 | 0.010 |
Why?
|
| Sperm Banks | 1 | 1994 | 7 | 0.010 |
Why?
|
| Chromosome Fragile Sites | 1 | 1994 | 26 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2021 | 80168 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 2016 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 1999 | 727 | 0.010 |
Why?
|
| Tissue Banks | 1 | 1995 | 184 | 0.010 |
Why?
|
| Homosexuality | 1 | 1994 | 267 | 0.010 |
Why?
|
| Chromosome Walking | 1 | 1993 | 25 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1994 | 436 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2000 | 1248 | 0.010 |
Why?
|
| Respiratory System | 1 | 1997 | 557 | 0.010 |
Why?
|
| Protons | 1 | 1998 | 1112 | 0.010 |
Why?
|
| Testis | 1 | 1996 | 794 | 0.010 |
Why?
|
| Placenta | 1 | 2001 | 1702 | 0.010 |
Why?
|
| Narcotics | 1 | 1994 | 336 | 0.010 |
Why?
|
| Ear, External | 1 | 1993 | 164 | 0.010 |
Why?
|
| Antibodies | 1 | 1980 | 2420 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1997 | 1085 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 1992 | 111 | 0.010 |
Why?
|
| Thailand | 1 | 1993 | 288 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1999 | 866 | 0.010 |
Why?
|
| Atrophy | 1 | 1997 | 1627 | 0.010 |
Why?
|
| Amino Acids | 1 | 1998 | 1713 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2012 | 26183 | 0.010 |
Why?
|
| HIV | 1 | 1999 | 1581 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3099 | 0.010 |
Why?
|
| Plasmids | 2 | 1987 | 2275 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15225 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 14490 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 1999 | 14641 | 0.010 |
Why?
|
| Nucleotides | 1 | 1993 | 450 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1997 | 1533 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 4158 | 0.010 |
Why?
|
| Hernia, Inguinal | 1 | 1993 | 220 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 3845 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1996 | 1074 | 0.010 |
Why?
|
| Fluorescence | 1 | 1992 | 749 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 1990 | 88 | 0.010 |
Why?
|
| HIV Infections | 1 | 1996 | 17275 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 1993 | 367 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15785 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 1991 | 352 | 0.010 |
Why?
|
| Cryopreservation | 1 | 1995 | 717 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 1992 | 624 | 0.000 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1988 | 31 | 0.000 |
Why?
|
| Hippocampus | 1 | 2001 | 3736 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15399 | 0.000 |
Why?
|
| Confidence Intervals | 1 | 1993 | 2925 | 0.000 |
Why?
|
| MNSs Blood-Group System | 1 | 1986 | 7 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1993 | 1593 | 0.000 |
Why?
|
| Equipment Design | 1 | 1995 | 3507 | 0.000 |
Why?
|
| Plasminogen Inactivators | 1 | 1986 | 37 | 0.000 |
Why?
|
| Central Nervous System Stimulants | 1 | 1994 | 1176 | 0.000 |
Why?
|
| Plasminogen | 1 | 1986 | 146 | 0.000 |
Why?
|
| Gastroesophageal Reflux | 1 | 1993 | 816 | 0.000 |
Why?
|
| Vitamin D-Binding Protein | 1 | 1986 | 131 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1997 | 10112 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 1996 | 3047 | 0.000 |
Why?
|
| Endothelium | 1 | 1986 | 764 | 0.000 |
Why?
|
| Neoplasms | 1 | 2012 | 22032 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1997 | 6570 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 10171 | 0.000 |
Why?
|
| Kidney | 2 | 1987 | 7016 | 0.000 |
Why?
|
| H-2 Antigens | 1 | 1980 | 358 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1980 | 513 | 0.000 |
Why?
|
| Globins | 1 | 1979 | 403 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 13591 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1993 | 12440 | 0.000 |
Why?
|
| United States | 2 | 2002 | 72136 | 0.000 |
Why?
|
| Major Histocompatibility Complex | 1 | 1980 | 928 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 1993 | 4673 | 0.000 |
Why?
|
| Incidence | 1 | 1993 | 21272 | 0.000 |
Why?
|
| Sodium | 1 | 1979 | 1588 | 0.000 |
Why?
|
| Neoplastic Stem Cells | 1 | 1981 | 1346 | 0.000 |
Why?
|
| Skin | 1 | 1987 | 4464 | 0.000 |
Why?
|
| Kinetics | 1 | 1980 | 6371 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1980 | 2836 | 0.000 |
Why?
|
| Hematopoiesis | 1 | 1980 | 2047 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1994 | 54137 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1980 | 2825 | 0.000 |
Why?
|